This indicates that the high expression of CIT can mediate the fibrosis progression of NASH, thereby leading to the occurrence and development of HCC, and TEAD4 and SOCS2 may affect HCC through pathways other than liver fibrosis. This evidence concerns the gene SOCS2 and metabolic dysfunction-associated steatohepatitis.